Skip to main content
Neuro-Oncology logoLink to Neuro-Oncology
. 2021 Aug 7;23(12):2125. doi: 10.1093/neuonc/noab176

Erratum to: Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: a phase II blinded randomized trial

Wen-Chi Yang 1,5,6, Ya-Fang Chen 2,4, Chi-Cheng Yang 7,8, Pei-Fang Wu 3, Hsing-Min Chan 1, Jenny Ling-Yu Chen 1,2, Guann-Yiing Chen 1,4, Jason Chia-Hsien Cheng 1,5,6, Sung-Hsin Kuo 1,5,6, Feng-Ming Hsu 1,5,6,
PMCID: PMC8643456  PMID: 34363389

In the originally published version of this manuscript, the affiliation ‘Graduate Institute of Oncology (W-C.Y., J.C-H.C., S-H.K., F-M.H.) and Cancer Research Center (W-C.Y., J.C-H.C., S-H.K., F-M.H.)’ was incomplete. It has now been updated as follows: ‘Graduate Institute of Oncology (W-C.Y., J.C-H.C., S-H.K., F-M.H.) and Cancer Research Center (W-C.Y., J.C-H.C., S-H.K., F-M.H.), National Taiwan University College of Medicine, Taipei, Taiwan’. In addition, in Table 1, item Primary cancer of the HA-WBRT group, the number of “Others: 3.0% (33)”, has been corrected to “Others: 3.0% (1)”.


Articles from Neuro-Oncology are provided here courtesy of Society for Neuro-Oncology and Oxford University Press

RESOURCES